{"id":"NCT01960348","sponsor":"Alnylam Pharmaceuticals","briefTitle":"APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis","officialTitle":"APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Patisiran (ALN-TTR02) in Transthyretin (TTR)-Mediated Polyneuropathy (Familial Amyloidotic Polyneuropathy-FAP)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-11","primaryCompletion":"2017-08","completion":"2017-08","firstPosted":"2013-10-10","resultsPosted":"2018-09-06","lastUpdate":"2024-04-22"},"enrollment":225,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["TTR-mediated Amyloidosis","Amyloidosis, Hereditary","Amyloid Neuropathies, Familial","Familial Amyloid Polyneuropathies","Amyloid Neuropathies","Amyloidosis, Hereditary, Transthyretin-Related"],"interventions":[{"type":"DRUG","name":"patisiran (ALN-TTR02)","otherNames":[]},{"type":"DRUG","name":"Sterile Normal Saline (0.9% NaCl)","otherNames":[]}],"arms":[{"label":"patisiran (ALN-TTR02)","type":"ACTIVE_COMPARATOR"},{"label":"Sterile Normal Saline (0.9% NaCl)","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of patisiran (ALN-TTR02) in patients with transthyretin (TTR) mediated amyloidosis. An open-label, single-arm, long-term follow-up extension study NCT02510261 (ALN-TTR02-006) was initiated to provide participants who completed this study with continued patisiran-LNP (lipid nanoparticle) treatment.","primaryOutcome":{"measure":"Modified Neuropathy Impairment Score +7 (mNIS+7)","timeFrame":"18mo","effectByArm":[{"arm":"Patisiran (ALN-TTR02)","deltaMin":-6.03,"sd":1.739},{"arm":"Placebo","deltaMin":27.96,"sd":2.602}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0000001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":6},"locations":{"siteCount":52,"countries":["United States","Argentina","Australia","Brazil","Bulgaria","Canada","Cyprus","France","Germany","Italy","Japan","Malaysia","Mexico","Netherlands","Portugal","South Korea","Spain","Sweden","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["38548524","36120830","31322739","30878017","30586695","29972753","28893208"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":54,"n":148},"commonTop":["Diarrhoea","Oedema peripheral","Fall","Nausea","Infusion related reaction"]}}